256 results on '"Balp, Maria-Magdalena"'
Search Results
2. Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
3. NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settings
4. The burden of nonalcoholic steatohepatitis (NASH) in the United States
5. Disease burden and predictors associated with non-response to antihistamine-based therapy in chronic spontaneous urticaria
6. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
7. Predicting Clinical Remission of Chronic Urticaria Using Random Survival Forests: Machine Learning Applied to Real-World Data
8. Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria
9. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
10. Clinical Remission of Chronic Spontaneous Urticaria (CSU): A Targeted Literature Review
11. The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review
12. Real-World Burden of Nonalcoholic Steatohepatitis
13. Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study
14. Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis
15. Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis
16. Frequency of Angioedema in Chronic Spontaneous Urticaria Patients: Report From the Urticaria Voices Study
17. Burden Of Angioedema Among Patients With Chronic Spontaneous Urticaria In The United States.
18. The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A real-world patient-reported outcomes study
19. The comparative burden of chronic spontaneous urticaria, atopic dermatitis and psoriasis in five European countries.
20. Predicting Chronic Spontaneous Urticaria Symptom Return After Omalizumab Treatment Discontinuation: Exploratory Analysis
21. Understanding Patient Preferences and Unmet Needs in Non-alcoholic Steatohepatitis (NASH): Insights from a Qualitative Online Bulletin Board Study
22. Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study
23. Treatment Patterns, Healthcare Resource Utilization, and Spending Among Medicaid-Enrolled Children with Chronic Idiopathic/Spontaneous Urticaria in the United States
24. Why a Complete Response Is the Treatment Aim in Chronic Spontaneous Urticaria
25. Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study
26. Clinical Features Associated with a Treatment-Refractory Phenotype in Chronic Spontaneous Urticaria (CSU)
27. Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey
28. The Burden of Chronic Urticaria from Brazilian Patients’ Perspective
29. Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
30. EQ-5D Utilities in Chronic Spontaneous/Idiopathic Urticaria
31. Preferences and Stated Adherence for Antibiotic Treatment of Cystic Fibrosis Pseudomonas Infections
32. Assessing Changes in Chronic Spontaneous/Idiopathic Urticaria: Comparisons of Patient-Reported Outcomes Using Latent Growth Modeling
33. The Cost of Diagnosing and Managing Non-alcoholic Steatohepatitis in Europe and the United States
34. 33834 Impact of chronic spontaneous urticaria on health-related quality of life in the United States
35. 33220 Health care resource utilization among adults with chronic spontaneous urticaria in the United States
36. 33826 Prevalence and clinical profile of patients with chronic spontaneous urticaria in the USA
37. 33224 Health care resource utilization among adults with chronic inducible urticaria in the United States
38. 53857 Urticaria Voices: Patients' and Physicians' Perceptions on Glucocorticoid Use in Chronic Spontaneous Urticaria
39. 52263 Impact of severity on the burden of chronic spontaneous urticaria in the United States
40. 54117 Disease journey and treatment outcomes: The real-world experience of patients with CSU
41. Validation of the Treatment Satisfaction Questionnaire for Medication in patients with cystic fibrosis
42. The Impact of Chronic Urticaria from the Patient’s Perspective: A Survey in Five European Countries
43. A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis
44. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
45. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
46. Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria
47. Le contrôle complet des symptômes de l’urticaire avec le ligélizumab aide à normaliser la qualité de vie
48. Clinical Remission of Chronic Spontaneous Urticaria (CSU): A Targeted Literature Review
49. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
50. Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.